BioCentury
ARTICLE | Company News

Amersham, Pharmacia, Novartis deal

September 23, 2002 7:00 AM UTC

AHM's Amersham Biosciences division (Piscataway, N.J.) licensed to NVS and PHA rights to green fluorescent protein (GFP) vectors for drug discovery research. GFP vectors, which are derived from jellyf...